Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Inventory (2016)

Viridian Therapeutics, Inc.\DE (VRDN) has 3 years of Inventory data on record, last reported at $64000.0 in Q4 2016.

  • For Q4 2016, Inventory fell 65.78% year-over-year to $64000.0; the TTM value through Dec 2016 reached $64000.0, down 65.78%, while the annual FY2016 figure was $64000.0, 65.78% down from the prior year.
  • Inventory reached $64000.0 in Q4 2016 per VRDN's latest filing, up from $62000.0 in the prior quarter.
  • Across five years, Inventory topped out at $536000.0 in Q2 2015 and bottomed at $62000.0 in Q3 2016.
  • Average Inventory over 3 years is $239018.5, with a median of $213000.0 recorded in 2016.
  • Peak YoY movement for Inventory: soared 177.52% in 2015, then crashed 82.97% in 2016.
  • A 3-year view of Inventory shows it stood at $179000.0 in 2014, then rose by 4.47% to $187000.0 in 2015, then plummeted by 65.78% to $64000.0 in 2016.
  • Per Business Quant database, its latest 3 readings for Inventory were $64000.0 in Q4 2016, $62000.0 in Q3 2016, and $213000.0 in Q2 2016.